Peptide & Compound Guide
At a glance
| Compound | Semax |
|---|---|
| Type | Synthetic peptide / ACTH-fragment analogue |
| U.S. regulatory context | Not FDA approved in the United States |
| Evidence level | Limited human evidence; regional use and research vary |
| Research area | Neurobiology, cognition and neurologic research |
What is Semax?
Semax is a synthetic peptide developed from an adrenocorticotropic-hormone fragment and discussed for cognitive and neurologic effects. It is not an FDA-approved medicine in the United States.
What does the research examine?
Published work includes preclinical research and human studies from limited settings. Replication, study quality and applicability to healthy users should be evaluated carefully.
What has not been established?
Mechanism, biomarker changes, animal findings and early clinical signals are not the same as proof that a compound safely improves meaningful health outcomes. Claims should be matched to the type, size and quality of evidence available.
Safety and regulatory context
Online nootropic claims frequently exceed the strength of available evidence.
Research sources
Use primary and authoritative sources when evaluating claims about this compound. Search results can change as new research is published.